Refine
Year of publication
Document Type
- Article (137)
- Preprint (75)
- Conference Proceeding (1)
Has Fulltext
- yes (213)
Is part of the Bibliography
- no (213)
Keywords
- BESIII (11)
- Branching fraction (9)
- e +-e − Experiments (6)
- Hadronic decays (4)
- Lepton colliders (4)
- Branching fractions (3)
- Charmed mesons (3)
- Charmonium (3)
- Electroweak interaction (3)
- Particle and Resonance Production (3)
- Quarkonium (3)
- e+-e− Experiments (3)
- Bhabha (2)
- Charm Physics (2)
- Charm physics (2)
- Cross section (2)
- Electroweak Interaction (2)
- Exotics (2)
- Initial state radiation (2)
- Leptonic, semileptonic & radiative decays (2)
- Particle decays (2)
- Spectroscopy (2)
- (E-) Recruiting (1)
- Actin (1)
- Activities of daily living (1)
- Angular distribution (1)
- Annihilation (1)
- Anti-kaon–nucleon physics (1)
- Antirheumatic agents (1)
- Anxiety (1)
- Anxiety disorders (1)
- BESIII detector (1)
- BI1361849 (1)
- Baryonic resonances (1)
- CP violation (1)
- CV9202 (1)
- Cardiomyopathy (1)
- Child (1)
- Clinical Trials and Observations (1)
- Clinical trial (1)
- Comparative effectiveness research (1)
- Complex I (1)
- Consensus (1)
- Covariance matrix (1)
- Cross section measurements (1)
- Crystal structure (1)
- D0 and D+ mesons (1)
- Dalitz decay (1)
- Dark photon (1)
- Dark sector (1)
- Dermatomyositis (1)
- Diagnosis (1)
- Dilated cardiomyopathy (1)
- D⁰ meson (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electron-pion identification (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- Fibre/foam sandwich radiator (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flavour Physics (1)
- Form factors (1)
- Freezeout (1)
- Graphs (1)
- Hadronic cross section (1)
- Hadrons (1)
- Heart (1)
- Heart transplantation (1)
- Heavy-ion reactions (1)
- High-pressure (1)
- HuR (1)
- Hyperons (1)
- Hypofractionated radiotherapy (1)
- IRES translation (1)
- Immunomonitoring (1)
- Internet-Stellenbörse (1)
- Interpersonal relationships (1)
- Invisible decays (1)
- Ionisation energy loss (1)
- Kaonic nuclei (1)
- Karriere-Website (1)
- Lactic acidosis (1)
- Low energy QCD (1)
- Mena/VASP (1)
- Mental health therapies (1)
- Mitochondrial disorder (1)
- Multi-wire proportional drift chamber (1)
- Multianvil (1)
- Multiple text comprehension (1)
- Muon anomaly (1)
- Myeloid Neoplasia (1)
- Neonatal (1)
- Neural network (1)
- Neutrinos (1)
- Non-small cell lung cancer (1)
- Partial wave analysis (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Partner Matching (1)
- Patients (1)
- Personalbeschaffung (1)
- Pion form factor (1)
- Plausibility (1)
- Polarization (1)
- Prognosis (1)
- Proton (1)
- Psychometrics (1)
- Psychotherapy (1)
- QCD (1)
- Quantum chromodynamics (1)
- Questionnaires (1)
- R value (1)
- Radiative decay (1)
- Rare decays (1)
- Rare-earth borate (1)
- Science text comprehension (1)
- Semi-leptonic decays (1)
- Spectrin (1)
- TR (1)
- Techniques Electromagnetic calorimeters (1)
- Terbium (1)
- Tracking (1)
- Transition radiation detector (1)
- Treatment (1)
- Trigger (1)
- Triple quarkonia (1)
- Vitamin (1)
- Water balance (1)
- Xenon-based gas mixture (1)
- Y (4260) (1)
- Y states (1)
- artifacts (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- available water capacity (1)
- bilin-binding photoreceptors (1)
- bortezomib (1)
- caspase-2 (1)
- center-of-mass energy (1)
- charmonium-like states (1)
- chemotherapeutic drug resistance (1)
- colon carcinoma cells (1)
- dE/dx (1)
- data quality (1)
- dimuon (1)
- diphoton (1)
- drought-stress (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- e+e− annihilation (1)
- electroencephalography (EEG) (1)
- forest site classification (1)
- hadronic events (1)
- inclusive J/ψ decays (1)
- induction regimen (1)
- kidney (1)
- lenalidomide (1)
- luminosity (1)
- mRNA active cancer immunotherapy (1)
- multicenter study (1)
- multiple myeloma (1)
- number of J/ψ events (1)
- photochemistry (1)
- photoisomerization (1)
- ppK − (1)
- renal failure (1)
- site classification system (1)
- time-resolved spectroscopy (1)
- trigger efficiency (1)
- Λ+c baryon (1)
- Σ hyperon (1)
Institute
- Physik (182)
- Medizin (16)
- Geowissenschaften (5)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
- Informatik (3)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (3)
- Biochemie und Chemie (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Biowissenschaften (2)
- Psychologie (2)
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p-Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p-Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p–Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
Background Today it is widely accepted that plastids are of cyanobacterial origin. During their evolutionary integration into the metabolic and regulatory networks of the host cell the engulfed cyanobacteria lost their independency. This process was paralleled by a massive gene transfer from symbiont to the host nucleus challenging the development of a retrograde protein translocation system to ensure plastid functionality. Such a system includes specific targeting signals of the proteins needed for the function of the plastid and membrane-bound machineries performing the transfer of these proteins across the envelope membranes. At present, most informations on protein translocation are obtained by the analysis of land plants. However, the analysis of protein import into the primitive plastids of glaucocystophyte algae, revealed distinct features placing this system as a tool to understand the evolutionary development of translocation systems. Here, bacterial outer membrane proteins of the Omp85 family have recently been discussed as evolutionary seeds for the development of translocation systems. Results To further explore the initial mode of protein translocation, the observed phenylalanine dependence for protein translocation into glaucophyte plastids was pursued in detail. We document that indeed the phenylalanine has an impact on both, lipid binding and binding to proteoliposomes hosting an Omp85 homologue. Comparison to established import experiments, however, unveiled a major importance of the phenylalanine for recognition by Omp85. This finding is placed into the context of the evolutionary development of the plastid translocon. Conclusion The phenylalanine in the N-terminal domain signs as a prerequisite for protein translocation across the outer membrane assisted by a primitive translocon. This amino acid appears to be optimized for specifically targeting the Omp85 protein without enforcing aggregation on the membrane surface. The phenylalanine has subsequently been lost in the transit sequence, but can be found at the C-terminal position of the translocating pore. Thereby, the current hypothesis of Omp85 being the prokaryotic contribution to the ancestral Toc translocon can be supported.
Interleukin (IL)-22 is a STAT3-activating cytokine displaying characteristic AU-rich elements (ARE) in the 3'-untranslated region (3'-UTR) of its mRNA. This architecture suggests gene regulation by modulation of mRNA stability. Since related cytokines undergo post-transcriptional regulation by ARE-binding tristetraprolin (TTP), the role of this destabilizing protein in IL-22 production was investigated. Herein, we demonstrate that TTP-deficient mice display augmented serum IL-22. Likewise, IL-22 mRNA was enhanced in TTP-deficient splenocytes and isolated primary T cells. A pivotal role for TTP is underscored by an extended IL-22 mRNA half-life detectable in TTP-deficient T cells. Luciferase-reporter assays performed in human Jurkat T cells proved the destabilizing potential of the human IL-22-3'-UTR. Furthermore, overexpression of TTP in HEK293 cells substantially decreased luciferase activity directed by the IL-22-3'-UTR. Transcript destabilization by TTP was nullified upon cellular activation by TPA/A23187, an effect dependent on MEK1/2 activity. Accordingly, IL-22 mRNA half-life as determined in TPA/A23187-stimulated Jurkat T cells decreased under the influence of the MEK1/2 inhibitor U0126. Altogether, data indicate that TTP directly controls IL-22 production, a process counteracted by MEK1/2. The TTP-dependent regulatory pathway described herein likely contributes to the role of IL-22 in inflammation and cancer and may evolve as novel target for pharmacological IL-22 modulation.
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.
Simple Summary: Renal insufficiency is frequently seen in newly diagnosed multiple myeloma and can be due to the disease itself but also caused by medical interventions or infections. Patients with severe renal insufficiency are known to have an adverse prognosis, but recently, it was shown that even moderately impaired kidney function can have long-term sequelae. Achieving quick disease control by effective antimyeloma therapy can lead to the recovery of renal function. We investigated the kidney-specific variables in a large cohort of 770 myeloma patients receiving three different three-drug regimens for initial myeloma treatment to learn more about the differential effects on kidney function in an early disease phase. All regimens had a positive impact on kidney function without a difference in the proportion of patients who reached normal renal function after three cycles. Interestingly, patients who received bortezomib, lenalidomide, and dexamethasone tended to have higher risk for a worse renal function following induction when compared to the initial values.
Abstract: Background: Preservation of kidney function in newly diagnosed (ND) multiple myeloma (MM) helps to prevent excess toxicity. Patients (pts) from two prospective trials were analyzed, provided postinduction (PInd) restaging was performed. Pts received three cycles with bortezomib (btz), cyclophosphamide, and dexamethasone (dex; VCD) or btz, lenalidomide (len), and dex (VRd) or len, adriamycin, and dex (RAD). The minimum required estimated glomerular filtration rate (eGFR) was >30 mL/min. We analyzed the percent change of the renal function using the International Myeloma Working Group (IMWG) criteria and Kidney Disease: Improving Global Outcomes (KDIGO)-defined categories. Results: Seven hundred and seventy-two patients were eligible. Three hundred and fifty-six received VCD, 214 VRd, and 202 RAD. VCD patients had the best baseline eGFR. The proportion of pts with eGFR <45 mL/min decreased from 7.3% at baseline to 1.9% PInd (p < 0.0001). Thirty-seven point one percent of VCD versus 49% of VRd patients had a decrease of GFR (p = 0.0872). IMWG-defined “renal complete response (CRrenal)” was achieved in 17/25 (68%) pts after VCD, 12/19 (63%) after RAD, and 14/27 (52%) after VRd (p = 0.4747). Conclusions: Analyzing a large and representative newly diagnosed myeloma (NDMM) group, we found no difference in CRrenal that occurred independently from the myeloma response across the three regimens. A trend towards deterioration of the renal function with VRd versus VCD may be explained by a better pretreatment “renal fitness” in the latter group.
Herein, the high-pressure/high-temperature synthesis (11 GPa, 650 °C) of Tb3B10O17(OH)5 in a modified Walker-type multianvil device is presented. The structure of this rare-earth borate was determined by single-crystal X-ray diffraction methods and was found to crystallize orthorhombically in the space group Pmn21 (no. 31) with the unit cell parameters a = 16.2527(4), b = 4.4373(1), and c = 8.8174(2) Å. The new compound was further characterized using infrared spectroscopy, energy-dispersive X-ray spectroscopy, second harmonic generation (SHG) measurements, and temperature-dependent X-ray powder diffraction. Tb3B10O17(OH)5 decomposes to β-Tb(BO2)3 at temperatures higher than 460 °C. With increasing temperatures, the formation of μ-TbBO3 was observed, which transforms to π-TbBO3 upon cooling.
This paper reports on Monte Carlo simulation results for future measurements of the moduli of time-like proton electromagnetic form factors, |GE | and |GM|, using the ¯pp → μ+μ− reaction at PANDA (FAIR). The electromagnetic form factors are fundamental quantities parameterizing the electric and magnetic structure of hadrons. This work estimates the statistical and total accuracy with which the form factors can be measured at PANDA, using an analysis of simulated data within the PandaRoot software framework. The most crucial background channel is ¯pp → π+π−,due to the very similar behavior of muons and pions in the detector. The suppression factors are evaluated for this and all other relevant background channels at different values of antiproton beam momentum. The signal/background separation is based on a multivariate analysis, using the Boosted Decision Trees method. An expected background subtraction is included in this study, based on realistic angular distribuations of the background contribution. Systematic uncertainties are considered and the relative total uncertainties of the form factor measurements are presented.